pyrazines has been researched along with Congenital Erythropoietic Porphyria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blouin, JM; Costet, P; de Verneuil, H; Duchartre, Y; Ged, C; Lain, A; Lalanne, M; Millet, O; Richard, E | 1 |
1 other study(ies) available for pyrazines and Congenital Erythropoietic Porphyria
Article | Year |
---|---|
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
Topics: Animals; Blotting, Western; Boronic Acids; Bortezomib; Circular Dichroism; DNA Primers; Erythroid Cells; Humans; Mice; Models, Molecular; Mutation, Missense; Porphyria, Erythropoietic; Porphyrins; Proteasome Inhibitors; Protein Folding; Pyrazines; Real-Time Polymerase Chain Reaction; Spectrometry, Fluorescence; Uroporphyrinogen III Synthetase | 2013 |